SANUWAVE Health Inc (SNWV) FinancialsSNWVFinancialSANUWAVE Health Inc

SANUWAVE Health Inc (SNWV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Accessories and parts, accounting for 65.8% of total sales, equivalent to $6.69M. Other significant revenue streams include Product and Other Revenue. Understanding this composition is critical for investors evaluating how SNWV navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, SANUWAVE Health Inc maintains a gross margin of 73.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.88%, while the net margin is -6.94%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SNWV converts its operational activities into shareholder value.

In the context of the broader market, SNWV competes directly with industry leaders such as NSPR and PAVM. With a market capitalization of $41.89M, it holds a significant position in the sector. When comparing efficiency, SNWV's gross margin of 73.65% stands against NSPR's -43.70% and PAVM's -269.70%. Such benchmarking helps identify whether SANUWAVE Health Inc is trading at a premium or discount relative to its financial performance.

Sanuwave's gross margin is strong at 73.65%, but the company has faced substantial net income losses, with a net income of -676,000 in Q2 2026, reflecting ongoing financial challenges. The forward P/E ratio is 18.2482, suggesting that the stock may be overvalued given its current financial performance.